Rate limiting step in fatty acid synthesis is?
What is the primary defect associated with type II hyperlipidemia?
Which of the following is increased in lipoprotein lipase deficiency?
Aromatase produces estrogen from -
In Retinitis pigmentosa, which fatty acid is found to be decreased in the retina?
Which of the following helps in the transport of fatty acids across the inner mitochondrial membrane?
What is the type of cholesterol primarily found in gallstones?
In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?
Which apolipoprotein is associated with an increased risk of Alzheimer's disease?
HDL is called good cholesterol because -
Explanation: ***Production of malonyl-CoA*** - The conversion of **acetyl-CoA to malonyl-CoA** is catalyzed by **acetyl-CoA carboxylase (ACC)**, which is the **rate-limiting enzyme** in fatty acid synthesis. - This step is highly regulated by **hormones** (e.g., insulin activates, glucagon inactivates) and **nutrient availability**, controlling the overall flux of fatty acid production. *Production of acetyl CoA* - While **acetyl-CoA** is the precursor for fatty acid synthesis, its production (e.g., from glycolysis via pyruvate dehydrogenase) is not the rate-limiting step for the synthesis pathway itself. - The availability of **acetyl-CoA** influences the pathway, but the committed step occurs later. *Production of oxaloacetate* - **Oxaloacetate** is primarily involved in the **citric acid cycle** and gluconeogenesis, and its production is not directly the rate-limiting step in fatty acid synthesis. - It combines with acetyl-CoA to form citrate, allowing acetyl-CoA to be shuttled out of the mitochondria. *Production of citrate* - **Citrate** is formed when **acetyl-CoA and oxaloacetate** combine in the mitochondria and is then transported to the cytoplasm to provide acetyl-CoA for fatty acid synthesis. - Although the availability of **cytoplasmic citrate** is important as a precursor for cytoplasmic acetyl-CoA and an allosteric activator of ACC, its production is not the rate-limiting step of fatty acid synthesis itself.
Explanation: ***LDL receptor*** - A defect in the **LDL receptor** leads to type II hyperlipidemia, characterized by elevated **LDL cholesterol** levels in the blood [1]. - This condition results in increased risk for **atherosclerosis** and cardiovascular diseases due to impaired cellular uptake of cholesterol [1,2]. *Apo-E* - Deficiencies of **Apo-E** typically result in type III hyperlipidemia, associated with **remnant lipoprotein clearance** issues rather than type II. - It affects metabolism of **chylomicron remnants** and intermediate density lipoproteins (IDL), not primarily LDL. *None* - This option incorrectly suggests that there is no defect associated with type II hyperlipidemia; in reality, it is primarily linked to **LDL receptor** dysfunction [1]. - The term "none" implies a lack of specific pathology, which is inaccurate in the context of hyperlipidemia types. *Lipoprotein lipase* - Deficiency in **lipoprotein lipase** leads to type I (or V) hyperlipidemia, characterized by increased **triglyceride** levels rather than just LDL. - It primarily impairs the hydrolysis of triglycerides in chylomicrons and VLDL, which differs from the LDL receptor's function [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 157-159. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 156-157.
Explanation: ***Chylomicrons*** - **Lipoprotein lipase (LPL)** is essential for hydrolyzing triglycerides within **chylomicrons** and VLDL, allowing fatty acids to be taken up by tissues. - Deficiency in LPL leads to a significant accumulation of **chylomicrons** in the plasma, as their degradation is impaired, resulting in **hypertriglyceridemia**. *VLDL* - While LPL also breaks down **VLDL**, the primary and most dramatic accumulation in LPL deficiency is seen with **chylomicrons** due to their larger triglyceride content and direct dependence on LPL for clearance after meals. - **VLDL** levels might also be elevated, but the hallmark is the very high **chylomicron** levels. *LDL* - **LDL** is formed from the catabolism of VLDL, and its levels are generally not directly increased due to a primary LPL deficiency. - LPL's main role is in triglyceride-rich lipoprotein metabolism, not directly in **LDL** catabolism. *HDL* - **HDL** plays a role in reverse cholesterol transport and is not directly metabolized by lipoprotein lipase. - In fact, in severe hypertriglyceridemia due to LPL deficiency, **HDL** levels may sometimes be low rather than increased.
Explanation: ***Androgen*** - **Aromatase** is an enzyme complex that converts **androgens** (specifically androstenedione and testosterone) into **estrogens** (estrone and estradiol, respectively). - This conversion is a key step in **estrogen biosynthesis** and occurs in various tissues, including the ovaries, placenta, brain, and adipose tissue. *Progesterone* - **Progesterone** is a precursor to androgens, but it is not directly converted to estrogen by aromatase. - It plays a primary role in the **menstrual cycle** and **pregnancy**. *Cortisol* - **Cortisol** is a **glucocorticoid hormone** produced in the adrenal cortex and is not a substrate for aromatase. - Its primary functions relate to stress response, metabolism, and immune regulation. *Aldosterone* - **Aldosterone** is a **mineralocorticoid hormone** produced in the adrenal cortex and is not involved in estrogen synthesis. - It primarily regulates **blood pressure** and electrolyte balance.
Explanation: ***Docosahexaenoic acid*** - **Docosahexaenoic acid (DHA)** is a crucial **omega-3 fatty acid** abundantly found in the **photoreceptor outer segments** of the retina. - Its reduced levels are linked to photoreceptor dysfunction and degeneration seen in conditions like **Retinitis Pigmentosa**, influencing membrane fluidity and visual function. - DHA comprises up to **50% of the fatty acids** in photoreceptor membranes and is essential for maintaining retinal structure and function. *Arachidonic acid* - **Arachidonic acid** is an **omega-6 fatty acid** primarily involved in **inflammatory pathways** and cellular signaling. - While present in the retina, its decrease is not typically associated with the pathogenesis of **Retinitis Pigmentosa**. *Linoleic acid* - **Linoleic acid** is an **omega-6 essential fatty acid** and a precursor to **arachidonic acid**, but it is not a direct structural component of photoreceptor membranes. - Its levels are not specifically decreased in **Retinitis Pigmentosa** as a primary factor. *Palmitic acid* - **Palmitic acid** is a **saturated fatty acid** present in retinal membranes but not specifically concentrated in photoreceptors. - Its levels are not characteristically decreased in **Retinitis Pigmentosa**, unlike the omega-3 fatty acid DHA.
Explanation: ***Carnitine*** - **Carnitine** plays a crucial role in transporting long-chain fatty acids from the **cytosol** into the **mitochondrial matrix** for beta-oxidation. - It acts as a shuttling molecule, forming **acylcarnitine** which can cross the inner mitochondrial membrane via the **carnitine-acylcarnitine translocase**. *Acyl carrier protein* - **Acyl carrier protein (ACP)** is primarily involved in **fatty acid synthesis** in the cytoplasm, not in the transport of fatty acids into mitochondria for degradation. - It carries acyl groups during the elongation reactions of fatty acid synthesis. *Lecithin-cholesterol acyltransferase* - **Lecithin-cholesterol acyltransferase (LCAT)** is an enzyme found in plasma that catalyzes the formation of **cholesterol esters**, which are then transported by lipoproteins. - It is involved in **cholesterol metabolism** and reverse cholesterol transport, not in the mitochondrial transport of fatty acids. *Carnitine and albumin* - While **carnitine** is essential for mitochondrial fatty acid transport, **albumin** transports fatty acids in the blood plasma, from adipose tissue to other tissues. - Albumin does not transport fatty acids across the inner mitochondrial membrane; its role is extra-mitochondrial and related to systemic transport.
Explanation: ***Crystalline cholesterol monohydrate*** - The predominant type of cholesterol found in gallstones is **crystalline cholesterol monohydrate** [1], which reflects the solid form of cholesterol precipitating in bile. - It is often associated with **cholesterol gallstones**, occurring when bile contains excessive cholesterol or insufficient bile salts. *Crystalline Cholesterol dihydrate* - Crystalline cholesterol dihydrate is less commonly associated with gallstones and generally forms in different circumstances, not typical of cholesterol stones. - This type does not represent the main component of gallstones, which primarily consist of monohydrate forms. *Amorphous cholesterol dihydrate* - Amorphous cholesterol dihydrate is not a recognized form typically found in gallstones, as gallstone pathology focuses on crystallized forms. - Amorphous substances are less stable than crystalline forms, making this option unlikely in the context of gallstones. *Amorphous cholesterol monohydrate* - Amorphous cholesterol monohydrate is not the major component found in gallstones; gallstones are more likely to be crystalline in structure. - This form lacks the stable crystalline structure needed to precipitate and form gallstones effectively. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 882.
Explanation: ***Chylomicrons*** - **Lipoprotein lipase (LPL)** is essential for the breakdown of **triglycerides** within chylomicrons, which are absorbed after a fatty meal. - In LPL deficiency, **chylomicron clearance** from the bloodstream is impaired, leading to their accumulation and elevated levels. *High-Density Lipoprotein (HDL)* - HDL particles are primarily involved in **reverse cholesterol transport** and are not directly affected by LPL deficiency in terms of their synthesis or initial concentration post-meal. - While LPL activity can influence HDL metabolism, a deficiency would not directly cause an acute increase in HDL levels following a fatty meal. *Very Low-Density Lipoprotein (VLDL)* - VLDL is synthesized in the liver to transport **endogenous triglycerides**, rather than dietary triglycerides. - While prolonged LPL deficiency can indirectly affect VLDL metabolism, it is not the primary lipoprotein that acutely accumulates in response to a fatty meal in this condition. *Low-Density Lipoprotein (LDL)* - LDL is formed from the catabolism of VLDL and **intermediate-density lipoprotein (IDL)**. - In LPL deficiency, the initial step of **triglyceride hydrolysis** for chylomicrons is impaired, making it unlikely for LDL to increase immediately after a fatty meal.
Explanation: ***APOE4*** - The **APOE4 allele** is the strongest genetic risk factor for **late-onset Alzheimer's disease (AD)**, significantly increasing the risk and lowering the age of onset. - Individuals with one copy of APOE4 have a 2-3 times higher risk, while those with two copies have an 8-12 times higher risk of developing AD compared to those with APOE3. *APOE3* - **APOE3** is the most common allele and is considered a **neutral risk factor** for Alzheimer's disease, serving as the reference for risk comparison. - It plays a normal role in **lipid metabolism** and **cholesterol transport** in the brain. *APOE2* - The **APOE2 allele** is associated with a **reduced risk** of Alzheimer's disease. - It is believed to be **protective** against AD, possibly by **improving amyloid-beta clearance** or reducing neuroinflammation. *APOB* - **Apolipoprotein B (APOB)** is primarily involved in the assembly and secretion of **chylomicrons** and **very-low-density lipoproteins (VLDL)** in the liver and intestine. - While important for lipid metabolism, it is **not directly implicated** as a genetic risk factor for Alzheimer's disease in the same way APOE variants are.
Explanation: ***Removes cholesterol from peripheral tissues*** - **High-density lipoprotein (HDL)** is known as "good cholesterol" due to its role in **reverse cholesterol transport**, a process where it collects excess cholesterol from peripheral cells and tissues. - This action helps to prevent the accumulation of cholesterol in arteries, thereby reducing the risk of **atherosclerosis** and cardiovascular disease. - HDL then transports this cholesterol to the liver for excretion via bile, completing the protective cycle. *Increases cholesterol delivery to peripheral tissues* - This is actually the opposite of HDL's function and describes the role of **LDL (low-density lipoprotein)**, which is considered "bad cholesterol." - LDL delivers cholesterol to peripheral tissues, and excess LDL can lead to **atherosclerotic plaque formation**. *Stimulates cholesterol synthesis in the liver* - HDL does not directly stimulate cholesterol synthesis in the liver; rather, its role is primarily in **cholesterol efflux** from cells and transport. - The liver's cholesterol synthesis is regulated by various factors, including dietary intake and cellular cholesterol levels via the **SREBP pathway**, but HDL does not upregulate hepatic cholesterol synthesis. *Activates enzymes that break down triglycerides* - While HDL does activate **LCAT (lecithin-cholesterol acyltransferase)** for cholesterol esterification, its primary "good" function is not the breakdown of triglycerides. - **Lipoprotein lipase (LPL)** is the primary enzyme responsible for triglyceride breakdown in lipoproteins like VLDL and chylomicrons.
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free